Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use

References

• Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264–1268. doi:10.1001/archopht.118.9.1264
   PubMed Web of Science ®Google Scholar
• Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157(4):799–806. doi:10.1016/j.ajo.2013.12.023
   PubMed Web of Science ®Google Scholar
• Uccello-Barretta G, Nazzi S, Zambito Y, Di Colo G, Balzano F, Sansò M. Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops. Int J Pharm. 2010;395(1–2):122–131. doi:10.1016/j.ijpharm.2010.05.031
   Web of Science ®Google Scholar
• Versura P, Profazio V, Balducci N, Campos EC. Efficacy of two-month treatment with Xiloial eyedrops for discomfort from disposable soft contact lenses. Clin Ophthalmol. 2010;4:1035–1041. doi:10.2147/OPTH.S10448
   Google Scholar
• Mateo Orobia AJ, Saa J, Ollero Lorenzo A, Herreras JM. Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease. Clin Ophthalmol. 2018;12:453–461. doi:10.2147/OPTH.S157853
   PubMed Web of Science ®Google Scholar
• Soumendra S, Rashmirekha S, Padma LN. Tamarind seed polysaccharide: a versatile biopolymer for mucoadhesive applications. J Pharm Biomed Sci. 2010;8:20.
   Google Scholar
• Iester M, Oddone F, Fogagnolo P, Frezzotti P, Figus M. Confocal Microscopy Study Group. Changes in the morphological and functional patterns of the ocular surface in patients treated with prostaglandin analogues after the use of TSP 0.5%® preservative-free eyedrops: a prospective, multicenter study. Ophthalmic Res. 2014;51(3):146–152. doi:10.1159/000357100
   Web of Science ®Google Scholar
• Cox SM, Nichols KK, Nichols JJ. Agreement between automated and traditional measures of tear film breakup. Optom Vis Sci. 2015;92(9):e257–63. doi:10.1097/OPX.0000000000000648
   Web of Science ®Google Scholar
• Wu S, Hong J, Tian L, Cui X, Sun X, Xu J. Assessment of bulbar redness with a newly developed keratograph. Optom Vis Sci. 2015;92(8):892–899. doi:10.1097/OPX.0000000000000643
   PubMed Web of Science ®Google Scholar
• Markoulli M, Duong TB, Lin M, Papas E. Imaging the tear film: a comparison between the subjective keeler tearscope-plus™ and the objective oculus® keratograph 5M and LipiView® interferometer. Curr Eye Res. 2018;43(2):155–162. doi:10.1080/02713683.2017.1393092
   PubMed Web of Science ®Google Scholar
• Bron A, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640–650. doi:10.1097/00003226-200310000-00008
   PubMed Web of Science ®Google Scholar
• Akiyama-Fukuda R, Usui T, Yoshida T, Yamagami S. Evaluation of tear meniscus dynamics using anterior segment swept-source optical coherence tomography after topical solution instillation for dry eye. Cornea. 2016;35(5):654–658. doi:10.1097/ICO.0000000000000807
   PubMed Web of Science ®Google Scholar
• Baek J, Doh SH, Chung SK. Comparison of tear meniscus height measurements obtained with the keratograph and fourier domain optical coherence tomography in dry eye. Cornea. 2015;34(10):1209–1213. doi:10.1097/ICO.0000000000000575
   Web of Science ®Google Scholar
• López-de la Rosa A, Pinto-Fraga J, Blázquez Arauzo F, Urbano Rodríguez R, González-García MJ. Safety and efficacy of an artificial tear containing 0.3% hyaluronic acid in the management of moderate-to-severe dry eye disease. Eye Contact Lens. 2017;43(6):383–388. doi:10.1097/ICL.0000000000000284
   Web of Science ®Google Scholar
• Nagahara Y, Koh S, Nishida K, et al. Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses. Clin Ophthalmol. 2015;9:1029–1031. doi:10.2147/OPTH.S86173
   PubMedGoogle Scholar
• Pérez-Bartolomé F, Martínez-de-la-Casa JM, Arriola-Villalobos P, et al. Ocular redness measured with the keratograph 5m in patients using anti-glaucoma eye drops. Semin Ophthalmol. 2018;33(5):643–650. doi:10.1080/08820538.2017.1395891
   Web of Science ®Google Scholar
• El Ameen A, Vandermeer G, Pisella PJ. Efficacy and patient tolerability of preservative‐free latanoprost compared with preservative prostaglandin analogs in patients with ocular hypertension or glaucoma. Acta Ophthalmol. 2016;94.
   Web of Science ®Google Scholar
• Abdelfattah NS, Dastiridou A, Sadda SR, Lee OL. Noninvasive imaging of tear film dynamics in eyes with ocular surface disease. Cornea. 2015;34:S48–52. doi:10.1097/ICO.0000000000000570
   PubMed Web of Science ®Google Scholar
• Kim YH, Kang YS, Lee HS, Choi W, You IC, Yoon KC. Effectiveness of combined tear film therapy in patients with evaporative dry eye with short tear film breakup time. J Ocul Pharmacol Ther. 2017;33(8):635–643. doi:10.1089/jop.2017.0019
   Web of Science ®Google Scholar
• Mun Y, Kwon JW, Oh JY. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease. BMC Ophthalmol. 2018;18(1):237. doi:10.1186/s12886-018-0910-3
   Web of Science ®Google Scholar
• Koh S, Ikeda C, Watanabe S, et al. Effect of non-invasive tear stability assessment on tear meniscus height. Acta Ophthalmol. 2015;93(2):e135–139. doi:10.1111/aos.12516
   Web of Science ®Google Scholar
• Markoulli M, Sobbizadeh A, Tan J, Briggs N, Coroneo M. The effect of optive and optive advanced artificial tears on the healthy tear film. Curr Eye Res. 2018;43(5):588–594. doi:10.1080/02713683.2018.1433860
   PubMed Web of Science ®Google Scholar